IPP Bureau
Cupid gets female condom variant UNFPA prequalified to supply 100% of upcoming South Africa tender
By IPP Bureau - January 25, 2025
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
Mankind Pharma Q3 FY25 PAT dips 16% to Rs. 385 Cr
By IPP Bureau - January 25, 2025
Q3 FY25 revenue up 24% to Rs 3,230 crore
Merck inaugurates expansion of its Peenya facility in Bengaluru
By IPP Bureau - January 25, 2025
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25
By IPP Bureau - January 24, 2025
PAT after MI is Rs. 41 crore which is 162% increase
Shilpa Pharma Lifesciences received CEP from EDQM for API, Teriflunomide
By IPP Bureau - January 24, 2025
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
Alivus Life Sciences delivers 12% revenue growth
By IPP Bureau - January 24, 2025
EBITDA margins expand to 31.3%
Emcure Pharmaceuticals inaugurates R&D centre in Ahmedabad
By IPP Bureau - January 24, 2025
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Syngene reports 18% jump in Q3 FY25 PAT at Rs. 131 Cr
By IPP Bureau - January 24, 2025
Reported revenue from operations up by 11% to Rs. 944 crores Reported PAT (after exceptional items) up by 18% to Rs. 131 crore
Neuland Labs board approves Capex of Rs. 342 Cr
By IPP Bureau - January 23, 2025
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Piramal Critical Care announces US launch of Chlorpromazine Hydrochloride for Injection
By IPP Bureau - January 23, 2025
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
Zydus announces USFDA Orphan Drug Designation to Usnoflast for treatment of ALS
By IPP Bureau - January 23, 2025
The company is committed to unlocking new frontiers in neuroscience and developing Usnoflast for patients with ALS
Strides Pharma debuts with ESG rating of 76/100 in the S&P Global’s CSA 2024
By IPP Bureau - January 23, 2025
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Dr Reddy’s Labs Q3 FY25 profit up 2% YoY at Rs. 1,413 Cr
By IPP Bureau - January 23, 2025
The revenue from operations in Q3 FY25 is Rs. 8,358.6 crore, up 16% YoY
Budget 2025: Industry expects tax incentives and thrust on affordable healthcare
By IPP Bureau - January 23, 2025
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Glenmark Pharmaceuticals USA launches Phytonadione Injectable Emulsion USP
By IPP Bureau - January 22, 2025
According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales of approximately $19.7 million
